Active

BOONE-GIELEN INVEST

Switched

BE0884462529

Rechtspersoon Public limited company 1 establishment

Isschot 24, 2460 Kasterlee Activiteiten van holdings

Active for

19 year, 10 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 325,787

▼ 4% vs 2024

Profit

Healthy

€ 172,908

▼ 9% vs 2024

Debts

Low

€ 2.9 million

▲ 16% vs 2024

BOONE-GIELEN INVEST from Kasterlee, company number BE0884462529, closed financial year 2025 with a result of € 172,908 after tax. For that financial year BOONE-GIELEN INVEST recorded a gross margin of € 325,787 and equity of € 2.7 million. Compared with financial year 2024, the result moved from € 189,320 to € 172,908. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 5, 2026.

What happened at BOONE-GIELEN INVEST?

What happened at BOONE-GIELEN INVEST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Boone-Gielen Consult BV stepped down as director. NBB
  • New annual accounts for financial year 2025: profit of € 172,908 (▼ 9% vs 2024). Source: NBB ↗
  • Boone-Gielen Consult BV became a director. NBB
  • New establishment in Kasterlee. KBO
  • Start of the company according to the CBE. KBO

In short

From € 230,980 profit in 2022 to € 172,908 profit in 2025.

Paid € 265,728 in corporate taxes since 2022.

Best year ever: 2022, with € 230,980 profit.

On average € 52,900 of value added per employee in 2023.

A new publication or filing at BOONE-GIELEN INVEST? We notify you, reason included.

Follow BOONE-GIELEN INVEST

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

BOONE-GIELEN INVEST

It owns 100% of Queens Apotheek, 100% of Apotheek Healthcorner, 100% of Huvefar, 99.5% of Apotheek Put and 99.5% of Yobera itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Boone-Gielen Consult BV

Director · represented by Guido Boone

since 2020 · until 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Isschot 24

2460 Kasterlee

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0884.462.529
VAT number
BE 0884.462.529
Registered office
Isschot 24, 2460 Kasterlee
Names & denominations
BOONE-GIELEN INVEST
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
23 October 2006
Peppol
Active · Active since 5 Feb 2026
Activities · NACE

Activiteiten van holdings

Managementactiviteiten van holdings

Holdings

Diverse ondersteunende activiteiten ten behoeve van voorzieningen

Beheer van residentiële gebouwen

Frequently asked questions

What is the enterprise number of BOONE-GIELEN INVEST?
The enterprise number of BOONE-GIELEN INVEST is BE0884462529.
What is the address of BOONE-GIELEN INVEST?
The registered office of BOONE-GIELEN INVEST is located at Isschot 24, 2460 Kasterlee.
When was BOONE-GIELEN INVEST founded?
BOONE-GIELEN INVEST was founded on 23 October 2006.
What is the main activity of BOONE-GIELEN INVEST?
The main activity of BOONE-GIELEN INVEST is "Activiteiten van holdings" (NACE code 64210).
Does BOONE-GIELEN INVEST have a website?
No website is currently known for BOONE-GIELEN INVEST.
How much profit did BOONE-GIELEN INVEST make in 2025?
BOONE-GIELEN INVEST posted a profit after taxes of € 172,908 in financial year 2025.
What is the revenue of BOONE-GIELEN INVEST?
As a small company, BOONE-GIELEN INVEST is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 325,787.
How many employees does BOONE-GIELEN INVEST have?
According to the 2025 annual accounts, BOONE-GIELEN INVEST has 0.5 full-time equivalents (FTE).
Where can I find the annual accounts of BOONE-GIELEN INVEST?
BOONE-GIELEN INVEST files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of BOONE-GIELEN INVEST?
According to the 2025 annual accounts, the directors of BOONE-GIELEN INVEST are: Boone-Gielen Consult BV.
Who owns BOONE-GIELEN INVEST?
It owns 100% of Queens Apotheek, 100% of Apotheek Healthcorner, 100% of Huvefar, 99.5% of Apotheek Put and 99.5% of Yobera itself.